Abcam PLC ABCM:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 11:01 AM EST
21.89quote price arrow down-1.03 (-4.49%)
Volume
47,788
52 week range
17.71 - 24.69

...

Loading . . .

KEY STATS

  • Open22.70
  • Day High22.70
  • Day Low21.66
  • Prev Close22.92
  • 52 Week High24.69
  • 52 Week High Date01/14/21
  • 52 Week Low17.71
  • 52 Week Low Date10/22/20
  • Market Cap5,120.54M
  • Shares Out216.17M
  • 10 Day Average Volume0.15M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Abcam PLC News

There is no recent news for this security.

Latest ABCM News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Abcam plc is a global life sciences company. The Company identifies, develops, and provides biological reagents and tools, which are required in a range of fields and applications including drug discovery, diagnostics and basic research. The Company’s solutions include research use only (RUO) proteomic tools and antibody development for clinical application. The RUO proteomic products include protein binding reagents, such as antibodies and immunoassays, and related reagents....
Alan Hirzel
Chief Executive Officer
Michael Baldock
Chief Financial Officer
Marc Perkins
General Counsel
Address
Discovery Drive
Cambridge Biomedical Campus, Hills Road
Cambridge
CB20AX
United Kingdom